Gilead Sciences, Inc. · NASDAQ:GILD
O'Day Daniel Patrick sold 112,429 Gilead Sciences, Inc. shares (Form 4)
Traded Nov 4 to Nov 5, 2026 · Filed Nov 6, 2026
From Nov 4 to Nov 5, 2026, O'Day Daniel Patrick (Director, Chairman & CEO) sold 112,429 Gilead Sciences, Inc. shares at an average US$175.16 for US$19.7M under a trading plan, leaving 551,683 shares. Filed Nov 6, 2026 (Form 4).
- Sold
- 112,429 shares
- Price
- US$175.16 average (US$175.16 to US$175.17)
- Value
- US$19.7M
- Holding after
- 551,683 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chairman & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | Common Stock | Option exercise | 102,619 | US$72.34 | 654,302 | Direct |
| Nov 4, 2026 | Common Stock | Sale | 102,619 | US$175.16 | 551,683 | Direct |
| Nov 5, 2026 | Common Stock | Option exercise | 9,810 | US$72.34 | 561,493 | Direct |
| Nov 5, 2026 | Common Stock | Sale | 9,810 | US$175.17 | 551,683 | Direct |
Source
Download original · View original at SEC
Related
- Gilead Sciences, Inc.
- O'Day Daniel Patrick
- Gilead Sciences, Inc. shareholders
- Form 4 · O'Day Daniel Patrick · Nov 2, 2026
- Form 4 · O'Day Daniel Patrick · Oct 2, 2026
- Form 4 · O'Day Daniel Patrick · Sep 11, 2026
- Form 4 · O'Day Daniel Patrick · Sep 2, 2026
- Form 4 · O'Day Daniel Patrick · Aug 4, 2026
- Form 4 · Mercier Johanna · Nov 17, 2026
- Form 4 · Dickinson Andrew D · Nov 17, 2026
- Form 4 · Kramer Kelly A. · Nov 16, 2026
- Form 4 · Cain Wettan Keeley M · Nov 9, 2026
- Form 4 · Mercier Johanna · Oct 16, 2026